Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.28%||63.66||1.0%||$540.48m|
|VRTX||Vertex Pharmaceuticals, Inc.||3.77%||268.35||1.9%||$479.39m|
|REGN||Regeneron Pharmaceuticals, Inc.||3.14%||681.91||2.6%||$435.36m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-0.47%||2.10||0.7%||$146.80m|
|EXAS||EXACT Sciences Corp.||-2.20%||52.00||17.7%||$143.85m|
|TXG||10X Genomics, Inc.||-0.80%||49.76||0.0%||$100.48m|
|BMRN||BioMarin Pharmaceutical, Inc.||0.80%||80.36||4.2%||$99.19m|
Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.